BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11931465)

  • 1. Characterization of a high-dose-rate 90Sr-90Y source for intravascular brachytherapy by using the Monte Carlo code PENELOPE.
    Asenjo J; Fernández-Varea JM; Sánchez-Reyes A
    Phys Med Biol; 2002 Mar; 47(5):697-711. PubMed ID: 11931465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosimetric comparison of two 90Sr/90Y sources for intravascular brachytherapy: an EGSnrc Monte Carlo calculation.
    Wang R; Li XA
    Phys Med Biol; 2002 Dec; 47(23):4259-69. PubMed ID: 12502048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Monte Carlo calculation of dosimetric parameters of 90Sr/90Y and 192Ir SS sources for intravascular brachytherapy.
    Wang R; Li XA
    Med Phys; 2000 Nov; 27(11):2528-35. PubMed ID: 11128305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monte Carlo dose calculations of beta-emitting sources for intravascular brachytherapy: a comparison between EGS4, EGSnrc, and MCNP.
    Wang R; Li XA
    Med Phys; 2001 Feb; 28(2):134-41. PubMed ID: 11243335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosimetric characteristics of the Novoste Beta-Cath 90Sr/Y source trains at submillimeter distances.
    Roa DE; Song H; Yue N; d'Errico F; Nath R
    Med Phys; 2004 May; 31(5):1269-76. PubMed ID: 15191319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monte Carlo dose characterization of a new 90Sr/90Y source with balloon for intravascular brachytherapy.
    Wang R; Li XA; Lobdell J
    Med Phys; 2003 Jan; 30(1):27-33. PubMed ID: 12557975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of a 90Sr/90Y radiation source train stepping for intravascular brachytherapy.
    Miften MM; Das SK; Shafman TD; Marks LB
    Med Phys; 2002 Dec; 29(12):2891-6. PubMed ID: 12512724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measured TG-60 dosimetric parameters of the Novoste Beta-Cath 90Sr/Y source trains for intravascular brachytherapy.
    Roa DE; Song H; Yue N; D'Errico F; Nath R
    Cardiovasc Radiat Med; 2002; 3(3-4):199-204. PubMed ID: 12974374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monte carlo parametric study of stent impact on dose for catheter-based intravascular brachytherapy with 90Sr/90Y.
    Ortego PM; Prieto C; Vano E
    Med Phys; 2004 Jul; 31(7):1964-71. PubMed ID: 15305447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calculation of beta-ray dose distributions from ophthalmic applicators and comparison with measurements in a model eye.
    Cross WG; Hokkanen J; Järvinen H; Mourtada F; Sipilä P; Soares CG; Vynckier S
    Med Phys; 2001 Jul; 28(7):1385-96. PubMed ID: 11488569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of gel dosimetry to measure the 3D dose distribution of a 90Sr/90Y intravascular brachytherapy seed.
    Massillon-Jl G; Minniti R; Mitch MG; Maryanski MJ; Soares CG
    Phys Med Biol; 2009 Mar; 54(6):1661-72. PubMed ID: 19242054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monte Carlo dose calculations in homogeneous media and at interfaces: a comparison between GEPTS, EGSnrc, MCNP, and measurements.
    Chibani O; Li XA
    Med Phys; 2002 May; 29(5):835-47. PubMed ID: 12033580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IVBTMC, a Monte Carlo dose calculation tool for intravascular brachytherapy.
    Chibani O; Li XA
    Med Phys; 2003 Jan; 30(1):44-51. PubMed ID: 12557978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absorbed dose assessment of cardiac and other tissues around the cardiovascular system in brachytherapy with 90Sr/90Y source by Monte Carlo simulation.
    Saghamanesh S; Karimian A; Abdi M
    Radiat Prot Dosimetry; 2011 Sep; 147(1-2):296-9. PubMed ID: 21831866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the radioanalytical methods used to assay stainless-steel-encapsulated, ceramic-based 90Sr-90Y intravascular brachytherapy sources.
    Collé R
    Appl Radiat Isot; 2000 Jan; 52(1):1-18. PubMed ID: 10670916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetric effect of source centering and residual plaque for beta-emitting catheter based intravascular brachytherapy sources.
    Sehgal V; Li Z; Palta JR; Bolch WE
    Med Phys; 2001 Oct; 28(10):2162-71. PubMed ID: 11695779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of EGS4/PRESTA multiple-scattering algorithms for 90Sr/90Y intravascular brachytherapy dosimetry.
    Wang R; Li XA; Yu CX
    Phys Med Biol; 2000 Aug; 45(8):2343-52. PubMed ID: 10958198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extrapolation chamber measurements of 90Sr + 90Y beta-particle ophthalmic applicator dose rates.
    Deasy JO; Soares CG
    Med Phys; 1994 Jan; 21(1):91-9. PubMed ID: 8164595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Verification of absolute dose rates for intravascular brachytherapy beta sources.
    Piessens M; Reynaert N
    Phys Med Biol; 2000 Aug; 45(8):2219-31. PubMed ID: 10958190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monte Carlo characterization of biocompatible beta-emitting 90Y glass seed incorporated with the radionuclide 153Sm as a SPECT marker for brachytherapy applications.
    Hadadi A; Sadeghi M; Sardari D; Khanchi A; Shirazi A
    J Appl Clin Med Phys; 2013 Sep; 14(5):90-103. PubMed ID: 24036862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.